Europe Sepsis Diagnostics Market to 2028 - By Size, Share, Growth by End User and Forecast| Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Sepsis Diagnostics Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Sepsis Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 High sepsis mortality rates
5.1.2 Need for rapid diagnosis

5.2 Market Opportunities

5.2.1 Development of POC diagnostics
5.2.2 Use of biomarkers

5.3 Future Trends

5.3.1 Demand in critical care settings
5.3.2 Government initiatives for better diagnostics

5.4 Impact of Drivers and Restraints

6. Europe Sepsis Diagnostics Market Regional Analysis

6.1 Europe Sepsis Diagnostics Market Overview

6.2 Europe Sepsis Diagnostics Market Revenue 2019-2028 (US$ Million)

6.3 Europe Sepsis Diagnostics Market Forecast Analysis

7. Europe Sepsis Diagnostics Market Analysis – by Product

7.1 Instruments

7.1.1 Overview
7.1.2 Instruments: Europe Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Reagents and Assays

7.2.1 Overview
7.2.2 Reagents and Assays: Europe Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Blood Culture Media

7.3.1 Overview
7.3.2 Blood Culture Media: Europe Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Software

7.4.1 Overview
7.4.2 Software: Europe Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Sepsis Diagnostics Market Analysis – by Technology

8.1 Molecular Diagnostics

8.1.1 Overview
8.1.2 Molecular Diagnostics : Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Sepsis Diagnostics Market Analysis – by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)

9. Europe Sepsis Diagnostics Market – Europe Analysis

9.1 Europe

9.1.1 Europe Sepsis Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
9.1.1.1 Europe Sepsis Diagnostics Market – Revenue and Forecast Analysis – by Country
9.1.1.1 UK: Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.1 UK: Europe Sepsis Diagnostics Market Breakdown, by Product
9.1.1.1.2 UK: Europe Sepsis Diagnostics Market Breakdown, by Technology
9.1.1.1.3 UK: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)

9.1.1.2 Germany: Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1 Germany: Europe Sepsis Diagnostics Market Breakdown, by Product
9.1.1.2.2 Germany: Europe Sepsis Diagnostics Market Breakdown, by Technology
9.1.1.2.3 Germany: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)

9.1.1.3 France: Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.1 France: Europe Sepsis Diagnostics Market Breakdown, by Product
9.1.1.3.2 France: Europe Sepsis Diagnostics Market Breakdown, by Technology
9.1.1.3.3 France: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)

9.1.1.4 Russia: Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.1 Russia: Europe Sepsis Diagnostics Market Breakdown, by Product
9.1.1.4.2 Russia: Europe Sepsis Diagnostics Market Breakdown, by Technology
9.1.1.4.3 Russia: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)

9.1.1.5 Italy: Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5.1 Italy: Europe Sepsis Diagnostics Market Breakdown, by Product
9.1.1.5.2 Italy: Europe Sepsis Diagnostics Market Breakdown, by Technology
9.1.1.5.3 Italy: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)

9.1.1.6 Rest of Europe: Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.1 Rest of Europe: Europe Sepsis Diagnostics Market Breakdown, by Product
9.1.1.6.2 Rest of Europe: Europe Sepsis Diagnostics Market Breakdown, by Technology
9.1.1.6.3 Rest of Europe: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Europe Sepsis Diagnostics Market Industry Landscape

11.1 Overview

11.2 Mergers and Acquisitions

11.3 Agreements, Collaborations, and Joint Ventures

11.4 New Product Launches

11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Abbott

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 F. HOFFMANN-LA ROCHE LTD.

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Immunexpress Inc.

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 BD

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Danaher (Beckman Coulter)

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Luminex Corporation

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 THERMO FISHER SCIENTIFIC INC.

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 bioMerieux SA

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 T2 Biosystems, Inc

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

12.10 Axis-Shield Diagnostics Ltd

12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix

13.1 About Business Market Insights